Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access
Feasibility of Using a Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access
1 other identifier
interventional
13
1 country
1
Brief Summary
Study conducted to confirm phrenic nerve stimulation using the a transvenous Phrenic Nerve Stimulator in the left jugular vein.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2018
CompletedStudy Start
First participant enrolled
May 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 6, 2018
CompletedSeptember 6, 2018
September 1, 2018
2 months
May 3, 2018
September 4, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Successful insertion of the LIVE Catheter into the left jugular vein and stimulation of phrenic nerves
To determine whether in an anesthetized (sedated, intubated, and mechanically ventilated) patient the LIVE Catheter can be inserted percutaneously in the left jugular vein and, via the electrical stimulator, to transvenously stimulate one or both phrenic nerves causing the diaphragm to contract
through study completion, an average of 14 days
Secondary Outcomes (1)
Absence of device related or procedure related adverse events
through study completion, an average of 14 days
Other Outcomes (1)
Tidal volume assessement
during the procedure only up to 3 hours
Study Arms (1)
Temporary diaphragmatic pacing
EXPERIMENTALThere is no comparator for this study. Single site and all patients are in the treatment allocated group of temporary diaphragmatic pacing with the LIVE Catheter which is inserted via the left jugular vein.
Interventions
Placement of a temporary LIVE Catheter central venous pacing device in the left jugular vein to pace the phrenic nerves and allow recruitment of the diaphragm muscle.
Eligibility Criteria
You may qualify if:
- years of age or older;
- Able and willing to give informed consent or whose legally authorized representative is able and willing to give informed consent;
- Able to undergo general anesthesia (sedation, intubation, and mechanical ventilation);
- Acceptable indication for atrial septal defect closure.
You may not qualify if:
- Subject has an ejection fraction of \< 30%
- Subject has a co-morbid illness or life expectancy \< 2 years
- Subject has experienced an acute myocardial infarction within 72 hours prior to this procedure
- Subject is contraindicated for or unwilling to take aspirin or anticoagulants
- Subject is in cardiogenic shock
- Subject has other cardiovascular disease requiring open heart surgery
- Subject is known to have a demonstrated intra cardiac thrombus on echocardiography
- Subject has been treated with paralytic medications within 72 hours prior to procedure
- Subject has significant thoracic abnormalities such that placement of a left subclavian line would be difficult
- Subject has a known or suspected phrenic nerve paralysis
- Subject has co-existing temporary or implanted cardiac electrical devices such as a pacemaker or defibrillator
- Subject has an active systemic infection or local infection at or around the insertion site
- Subject is known or suspected to be pregnant or is lactating
- Subject will be unavailable for, or is unwilling to comply with, follow up requirements of the protocol
- Subject is currently enrolled in any other study of an investigational drug or device who has received treatment under that protocol with the investigational product during the 30 days prior to screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Italian Hospital
Asunción, Casa Zanotti, Paraguay
Related Publications (13)
Michalek P, Kautznerova D. Combined use of ultrasonography and neurostimulation for therapeutic phrenic nerve block. Reg Anesth Pain Med. 2002 May-Jun;27(3):306-8. No abstract available.
PMID: 12016605BACKGROUNDEscher DJ, Furman S, Solomon N, Schwedel JB. Transvenous pacing of the phrenic nerves. Am Heart J. 1966 Aug;72(2):283-4. doi: 10.1016/0002-8703(66)90456-x. No abstract available.
PMID: 5915563RESULTEscher DJ, Ashley W, Ertag W, Parker B, Furman S, Robinson G. Clinical control of respiration by transvenous phrenic pacing. Trans Am Soc Artif Intern Organs. 1968;14:192-7. No abstract available.
PMID: 4882945RESULTEisele JH, Noble MI, Katz J, Fung DL, Hickey RF. Bilateral phrenic-nerve block in man: technical problems and respiratory effects. Anesthesiology. 1972 Jul;37(1):64-9. doi: 10.1097/00000542-197207000-00012. No abstract available.
PMID: 5050104RESULTAubier M, Murciano D, Lecocguic Y, Viires N, Jacquens Y, Squara P, Pariente R. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985 Aug 15;313(7):420-4. doi: 10.1056/NEJM198508153130705.
PMID: 3860734RESULTIshii K, Kurosawa H, Koyanagi H, Nakano K, Sakakibara N, Sato I, Noshiro M, Ohsawa M. Effects of bilateral transvenous diaphragm pacing on hemodynamic function in patients after cardiac operations. Experimental and clinical study. J Thorac Cardiovasc Surg. 1990 Jul;100(1):108-14.
PMID: 2366549RESULTAllen GM, McKenzie DK, Gandevia SC, Bass S. Reduced voluntary drive to breathe in asthmatic subjects. Respir Physiol. 1993 Jul;93(1):29-40. doi: 10.1016/0034-5687(93)90065-i.
PMID: 8367614RESULTMulvey DA, Aquilina RJ, Elliott MW, Moxham J, Green M. Diaphragmatic dysfunction in neuralgic amyotrophy: an electrophysiologic evaluation of 16 patients presenting with dyspnea. Am Rev Respir Dis. 1993 Jan;147(1):66-71. doi: 10.1164/ajrccm/147.1.66.
PMID: 8420434RESULTMcKenzie DK, Allen GM, Gandevia SC. Reduced voluntary drive to the human diaphragm at low lung volumes. Respir Physiol. 1996 Aug;105(1-2):69-76. doi: 10.1016/0034-5687(96)00021-7.
PMID: 8897652RESULTOo T, Watt JW, Soni BM, Sett PK. Delayed diaphragm recovery in 12 patients after high cervical spinal cord injury. A retrospective review of the diaphragm status of 107 patients ventilated after acute spinal cord injury. Spinal Cord. 1999 Feb;37(2):117-22. doi: 10.1038/sj.sc.3100775.
PMID: 10065750RESULTAhn B, Beaver T, Martin T, Hess P, Brumback BA, Ahmed S, Smith BK, Leeuwenburgh C, Martin AD, Ferreira LF. Phrenic nerve stimulation increases human diaphragm fiber force after cardiothoracic surgery. Am J Respir Crit Care Med. 2014 Oct 1;190(7):837-9. doi: 10.1164/rccm.201405-0993LE. No abstract available.
PMID: 25271750RESULTGermany R, Joseph S, James K, Kao A. A novel therapeutic approach for the treatment of central sleep apnea: The remede(R) system. Cardiovasc Revasc Med. 2014 Jun;15(4):235-9. doi: 10.1016/j.carrev.2014.03.007. Epub 2014 Mar 21.
PMID: 24726495RESULTLinhart M, Nielson A, Andrie RP, Mittmann-Braun EL, Stockigt F, Kreuz J, Nickenig G, Schrickel JW, Lickfett LM. Fluoroscopy of spontaneous breathing is more sensitive than phrenic nerve stimulation for detection of right phrenic nerve injury during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014 Aug;25(8):859-865. doi: 10.1111/jce.12431. Epub 2014 May 18.
PMID: 24724724RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Linda Clark, RN
Lungpacer Medical Inc.
- PRINCIPAL INVESTIGATOR
Adrian Ebner, MD
Italian Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2018
First Posted
September 6, 2018
Study Start
May 7, 2018
Primary Completion
June 30, 2018
Study Completion
August 30, 2018
Last Updated
September 6, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share
Lungpacer may at any time publish the results of and information pertaining to the investigation subject only to compliance with regulatory requirements pertaining to patient protected health information